Impala
Overview
Information regarding an AI tool named ‘Impala’ from AliveCor, specifically designed for a physician directory, could not be found through web searches. Instead, ‘Impala’ (FDA K232035) is a portable 12-Lead resting electrocardiograph (ECG) device developed by AliveCor. It is designed for healthcare professionals to acquire diagnostic-bandwidth ECG leads and generate a 12-Lead ECG recording in settings where traditional 10-electrode, 12-lead ECG recorders are impractical due to size, time, or the need for specialized clinicians. AliveCor is primarily known for its innovative personal ECG devices, such as KardiaMobile and Kardia 12L, and AI-powered algorithms that assist in the detection of cardiac arrhythmias and other cardiac conditions. The company’s focus is on transforming cardiac care through accessible, AI-driven solutions for heart health monitoring.
Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Key Features
- Portable 12-Lead ECG acquisition
- Acquires 4 standard diagnostic-bandwidth leads (I, II, V1 or V2, V4)
- Derives 4 standard diagnostic-bandwidth leads (aVL, aVR, aVF, III)
- Software generates remaining leads (V2 or V1, V3, V5, V6) for 12-Lead recording
- AI technology (KAIu2122 12L) for cardiac determinations
- Detects life-threatening cardiac conditions, including heart attacks
- Reduced leadset for easier placement (single cable with 5 electrodes for 8 diagnostic-quality leads)
- Designed for rapid cardiac assessment
- Integration with AliveCor's ecosystem (e.g., KardiaStation app)
- Medical-grade heart data
Use Cases
- Recording diagnostic-bandwidth resting ECGs by healthcare professionals
- Use in physician offices where traditional 12-lead ECGs are impractical
- Deployment in 'minute clinics' and remote/field locations
- Use by first responders for rapid cardiac assessment
- Cardiac monitoring for adult patients (18 years and older)
- Integration into existing clinical workflows for ECG data analysis
What Physicians Need to Know
Impala, with its AI-powered 12-lead ECG capabilities, offers a portable and efficient solution for cardiac rhythm and morphological analysis in various healthcare settings where traditional 12-lead ECGs may be impractical. While it provides comprehensive detection for numerous arrhythmias and morphologies, including acute MI and ischemia, physicians should be aware that some chest leads are synthesized and not intended for diagnostic use, potentially missing findings limited to those specific leads. Leveraging the robust integration options (EHR, SDK, API) can streamline workflow and enhance remote patient monitoring. The real-time analysis and alerts, coupled with the ability to detect a broad range of conditions, can aid in rapid clinical decision-making and improve patient management.
AliveCor provides extensive integration capabilities through its EHR Integration, Software Development Kit (SDK), and Application Programming Interface (API). This allows for seamless data flow of ECGs into existing electronic health record systems (e.g., GE HealthCare's MUSEu2122 NX) and enables developers to embed AliveCor's ECG recording and AI analysis technology into their own mobile applications. The API facilitates access to patient ECG data stored in the AliveCor cloud, supporting streamlined workflows and remote patient management platforms. Webhook notifications can further enhance real-time data exchange by alerting integrated systems when new ECGs are available.
Details
| Category | Cardiology AI, Clinical Decision Support & Reference |
| Pricing | Contact for pricing — N/A |
| Deployment | Portable device, integrated with mobile applications/platforms. |
| Compliance | |
| BAA Available | Unknown AI-estimated |
| HIPAA Compliant | Unknown AI-estimated |
| FDA Status |
1 AI-estimated AliveCor's 'Impala' device received FDA 510(k) clearance (K232035) on June 7, 2024, as a portable 12-Lead resting electrocardiograph (ECG) device. It is intended for use by healthcare professionals to record diagnostic-bandwidth resting ECGs. |
| Integrations | |
| EHR | Not specified |
| Specialties | Cardiology, Emergency Medicine |
What the Web Says
AliveCor's Impala, also known as the Kardia 12L System, is a prescription-only, professional-grade electrocardiograph designed for portable 12-lead ECG analysis. It aims to bridge the gap between traditional ECG machines and consumer devices, offering a simplified acquisition method with five electrodes instead of ten. The system is highly regarded by healthcare professionals for its ability to provide clinical-grade data in various settings, including remote monitoring and physician offices.
Overall: MixedStrengths
- Provides professional-grade 12-lead ECG analysis with high accuracy.
- Simplifies ECG acquisition using only 5 electrodes compared to the standard 10.
- Offers high-resolution displays and sophisticated dual-mode analysis (Symptomatic vs. Asymptomatic) through the KardiaStation app.
- Cost-effective and time-effective alternative to traditional 12-lead ECGs in community diagnosis and monitoring of atrial fibrillation.
- Highly portable, fitting in a small carrying case, making it suitable for remote or field use.
- Excels at detecting atrial fibrillation with accuracy comparable to standard ECGs.
Limitations
- The synthesized leads are for informational purposes only and not for primary diagnostic decision-making.
- Primarily designed for clinical and acute settings, not continuous daily personal use without physician supervision.
- Some users report that the accompanying app is heavily geared towards pushing subscriptions, with basic functionalities locked behind a paywall.
- Customer service has received negative feedback regarding unresponsiveness and issues with warranty claims.
- WiFi connectivity can be a challenge during home visits in community settings, delaying data upload.
- Clinician reviews may not be available in all regions outside of specific countries.
Based on reviews from: AliveCor Kardia 12L System Review: Professional Grade Remote 12-Lead ECG Analysis, Physician review of the iPhone AliveCor ECG heart monitor, the clinical reality of the device, Thoughts/ recommendations on AliveCor vs Apple Watch for ECG? - Reddit, Single-lead ECGs (AliveCor) are a feasible, cost-effective and safer alternative to 12-lead ECGs in community diagnosis and monitoring of atrial fibrillation - PMC, Exploring the AliveCor Kardia Heart Monitor - Inteliora, Customer Ratings & Reviews - Best Buy, My Review of AliveCor Kardia Mobile EKG for Heart Palpitations - Natural Rhythm Nutrition, AliveCor Employee Reviews | Comparably, AliveCor | BBB Complaints | Better Business Bureau, Impala Reviews 2026: Details, Pricing, & Features | G2, Clinician reviews with AliveCor/KardiaMobile: not always available : r/AFIB - Reddit, Top 10 Impala Alternatives & Competitors in 2026 - G2, 6 L Kardia Mobile is it a good model? Any advice or tips is helpful : r/AFIB - Reddit, Kardiamobile devices, what's your experience? : r/AFIB - Reddit, KardiaMobile 6L: Excellent hardware, but the app is basically a paywall with a heartbeat, Impel Reviews 2026: Details, Pricing, & Features - G2, Case Review: What's an Impella? - HMP Global Learning Network, Read Customer Service Reviews of alivecor.com | 3 of 5 - Trustpilot Reviews, Read Customer Service Reviews of alivecor.com - Trustpilot, Read Customer Service Reviews of alivecor.com | 3 of 5 - Trustpilot
Last updated: 2026-07-21
Ratings & Reviews
Rate Impala
Press & Coverage
No FAQs available yet for this tool.
Compare Impala
VS
VS
VS
VS
Investors who backed Impala
Funded through the company that built this tool.
